Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of ...
Orforgliprion caused an average 11% weight loss among overweight and obese people after a year and a half, researchers ...
Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore ...
TUESDAY, Sept. 16, 2025 (HealthDay News) — A triple-sized weekly dose of Ozempic works better to help people with obesity ...
The global injection pen market is set to witness a growth rate of 7% in the next 5 years. Rising prevalence of chronic ...
Modular Medical (MODD) announced Institutional Review Board approval to conduct an in-house feasibility study of its next-generation Pivot insulin ...
The National on MSN
Is microdosing the answer to costly weight loss drugs?
Microdosing weight loss drugs, a growing global trend, could offer a new gateway solution for obesity for those priced out of the rising costs of drugs like Wegovy and Mounjaro. Weight loss is a major ...
Use of MODD1 on clinicians with Type 1 diabetes SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery tec ...
Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Great. I think we can get started, everyone. Kallum Titchmarsh here from the Life Sciences team at Morgan Stanley.
[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) announced that it began converting its manufacturing line to produce next-generation insulin pumps. The company completed its ...
SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback